Navigation Links
Valeant Pharmaceuticals To Present At Industry Conferences
Date:12/20/2013

LAVAL, Quebec, Dec. 20, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that members of its senior management team will make presentations at the following industry conferences:

  • The Goldman Sachs Healthcare CEOs Unscripted: A View From the Top on Tuesday, January 7, 2014 at 2:30 p.m. ET.  The conference will be held at the InterContinental Boston in Boston, MA.
  • The 32nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2012 at 3:30 p.m. PT. The conference will be held at the Westin St. Francis in San Francisco, CA.

A live webcast and audio archive of the presentations will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)...   TyrNovo , s NT219 ... cancer drug resistance and would ...   NT219 is a novel proprietary ... oncogenic pathways ( IRS1/2 and STAT3) highly ... the tumor .   NT219 has ...
(Date:1/12/2017)... 2017 This new report from VPGMarketResearch contains ... of the German hospital microbiology testing market, including:  ... hospital laboratory practice, as well as key economic, regulatory, ... during the next ten years.  ... and etiology of major infectious diseases and microorganisms.  ...
(Date:1/12/2017)... -- Harrington Discovery Institute at University Hospitals in ... Drug Discovery Foundation (ADDF) have expanded their collaboration ... Alzheimer,s disease. Together, the two organizations will jointly ... academic researchers. By leveraging their combined expertise, investment, ... will advance Alzheimer,s disease drug discovery projects of ...
Breaking Medicine Technology:
(Date:1/13/2017)... ... January 13, 2017 , ... The 18th European Congress: Perspectives in Lung Cancer ... 2017. This Congress is expertly designed to meet the educational needs of European ... cancer. , Chaired by Dr. Giorgio V. Scagliotti, Professor of Oncology at the University ...
(Date:1/13/2017)... ... January 13, 2017 , ... KOAMTAC ®, Inc., a leading ... the next generation companion scanner and data collector at the National Retail Federation’s Big ... created as an answer to the market’s need for more compact and rugged devices ...
(Date:1/13/2017)... ... ... inventor from Pahrump, Nev., used an unsavory medical experience to think of a way to ... urine bag for a half year due to lazy bladder," he said. "Keeping these things ... better way to do this." , He then designed and created a prototype of the ...
(Date:1/13/2017)... ... ... People who have sensitive teeth are about as common as those who do ... dental hygiene products in the market contain chemical ingredients that only aggravate the condition ... oral care routine to keep their teeth white and healthy is a struggle with ...
(Date:1/13/2017)... Okla. (PRWEB) , ... January 13, 2017 , ... Friday, ... the area of the game room, increasing the size of the location to 90,000 ... Course, an 8-hole mini golf course that takes customers on an educational tour of ...
Breaking Medicine News(10 mins):